|
EZH2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.661900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.573600E-02 |
| Normal-vs-Stage2 |
7.996200E-01 |
| Normal-vs-Stage3 |
1.320190E-01 |
| Normal-vs-Stage4 |
1.318260E-02 |
| Stage1-vs-Stage2 |
5.422000E-03 |
| Stage1-vs-Stage3 |
2.804000E-01 |
| Stage1-vs-Stage4 |
2.467800E-01 |
| Stage2-vs-Stage3 |
7.828200E-02 |
| Stage2-vs-Stage4 |
4.084600E-03 |
| Stage3-vs-Stage4 |
7.176100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.814000E-02 |
| Normal-vs-AfricanAmerican |
3.205600E-01 |
| Normal-vs-Asian |
3.406200E-02 |
| Caucasian-vs-AfricanAmerican |
4.829000E-01 |
| Caucasian-vs-Asian |
7.585400E-01 |
| AfricanAmerican-vs-Asian |
4.267400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.990500E-02 |
| Normal-vs-Female |
6.274100E-02 |
| Male-vs-Female |
7.715000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.392250E-02 |
| Normal-vs-Age(41-60Yrs) |
2.719600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.643700E-02 |
| Normal-vs-Age(81-100Yrs) |
6.336200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.384800E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.850600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.124000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.269600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.932180E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.336950E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.521000E-01 |
| Classical-VS-Follicular |
4.64789999998771E-06 |
| Classical-VS-Other |
2.967000E-01 |
| Classical-VS-Normal |
1.456240E-02 |
| Tall-VS-Follicular |
6.183100E-03 |
| Tall-VS-Other |
2.487400E-01 |
| Tall-VS-Normal |
4.215900E-02 |
| Follicular-VS-Other |
6.401600E-01 |
| Follicular-VS-Normal |
8.832400E-01 |
| Other-VS-Normal |
5.410200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.186210E-01 |
| Normal-vs-N1 |
2.650400E-02 |
| N0-vs-N1 |
1.624790E-01 |
|
|
